| Thursday 14th August 2008 | ||||||||||
| 0700 - 1700 | Registration Desk Open | |||||||||
| 0830 - 1000 | Plenary Session 4 PL04 Bayside Auditorium B |
|||||||||
| What is the Future of Immunosuppression in Clinical Transplantation? | ||||||||||
| Chairs: Philip O'Connell, Raimund Margreiter | ||||||||||
| 0830 | Mechanisms of Efficacy and Toxicity of New Immunosuppressive Agents | |||||||||
| Paul Keown (Vancouver, Canada) | ||||||||||
| 0900 | Clinical T Regulatory Cell Therapy a Clinical Reality? | |||||||||
| Maria Grazia Roncarolo (Milan, Italy) | ||||||||||
| 0930 | Clinical Tolerance - Will It Get Out of the Laboratory? | |||||||||
| Hugh Auchincloss (Bethesda, USA) | ||||||||||
| 1000 - 1030 | Morning Tea | |||||||||
| 1030 - 1200 | Concurrent Oral Session 51 THO51 Bayside Auditorium B |
Concurrent Oral Session 52 THO52 Parkside Auditorium |
Concurrent Oral Session 53 THO53 Bayside Auditorium A |
Concurrent Oral Session 54 THO54 Bayside Room 102 |
Concurrent Oral Session 55 THO55 Parkside Ballroom B |
Concurrent Oral Session 56 THO56 Parkside 110A |
Concurrent Oral Session 57 THO57 Bayside Room 204 A & B |
Concurrent Oral Session 58 THO58 Bayside Gallery |
Concurrent Oral Session 59 THO59 Bayside Room 103 |
Concurrent Oral Session 60 THO60 Parkside 110 B |
| Predictors of Renal Transplant Outcomes | Liver Outcomes 2 | Steroid Avoidance and Mycophenolates | Histocompatibility | Tolerance and T Regulatory Cells | T Cells and NK Cells | CAN and Antibodies | Organ Donation - Progress and Controversies | Islet Transplantation - Alternative Strategies | Mechanical Circulatory Support | |
| Chairs: Alain Assounga, Harry Moody | Chairs: Francis Yao, Nick Shackel | Chairs: Dirk Kuypers, Moses Wavamunno | Chairs: Elaine Reed, Frans Claas | Chairs: Andrew Lichtman, Bruce Hall | Chairs: Randall Faull, Nicholas Jones | Chairs: Paul Terasaki, Robert Colvin | Chairs: Thomas Mone, Kevin O'Connor | Chairs: Robert Deans, Andrew Posselt | Chairs: Robert Higgins, Philip Spratt | |
| 1030 | Validation Of An Algorithm For Diagnosis Of Coronary Artery Disease And Predicting Cardiac Events In High-Risk Renal Transplant Candidates. | The Familial Amyloidotic Polyneuropathy World Transplant Register (Fapwtr) View On Liver Transplantation For Transthyretin Systemic Amyloidosis Disorders | Steroid Immunosuppression Induces Changes In The Glucocorticoid Receptor | Humoral Responses To Donor Hla Antigens During Acute Rejection Are Independent Predictors Of Renal Allograft Loss | Combine Tgf-Beta/Fc And Rapamycin For Regulatory T Cells Generation And Allograft Tolerance Induction. | B Cells Promote Generation Of Cd4 And Cd8 Alloreactive Memory T Cells | Circulating Markers Of Endothelial Dysfunction Interact With Proteinuria In Predicting Mortality In Renal Transplant Recipients | Living Liver Donation: A Question Of Credibility | Effect Of Nf-Fèb Inhibition By Dhmeq On Islet Transplantation In Mice | Weaning From Left Ventricular Assist Devices In Patients With Idiopathic Dilated Cardiomyopathy: Long-Term Results And Predictability Of Outcome After Weaning |
| Jose JG Lima | Henryk E. Wilczek | Ian Hutchinson | Matthew Everly | WENSHENG ZHANG | Yue-Harn Ng | Rutger Van Ree | Burckhardt Ringe | Masaaki Watanabe | Hans Lehmkuhl | |
| 1040 | Counterintuitive Association Between Pre-Transplant Body Mass Index (Bmi) During Hemodialysis Treatment And 5-Year Post-Transplant Mortality In 18,501 Ckd Patients | Hereditary Fibrinogen A A Alpha-Chain Amyloidosis; Phenotypic Characterization And The Role Of Liver Transplantation | Steroid Avoidance After Renal Transplantation: Results Of A Prospective And Randomized Trial Using Fresenius Atg | Successful Deceased And Living Donor Kidney Transplantation After Desensitization Therapy In The Presence Of Donor Specific Antibodies (Dsa): Determination Of Acceptable Pre- And Post Transplant Dsa Levels | Induction Of Regulatory T Cells By Perioperative Donor Splenocyte Cotransplantation In Allogenic Pulmonary Transplantation | In Vivo Time-Lapse Imaging Of Naïve T Cells Conversion To Regulatory T Cells In Allograft Islet Transplantation | Estimation Of Renal Allograft Half Life In Cohorts With Different Follow Up | Sustained Impact Of The Donor Action Methodology On Donation Practices: A 7-Yearfollow-Up In 4 European Countries | Ppar Gamma Mediates The Protective Effects Of Carbon Monoxide In Islet Transplantation | Echocardiographic Prediction Of Short-Term Outcome In Patients With Idiopathic Dilated Cardiomyopathy Referred For Transplantation |
| Kamyar Kalantar-Zadeh | John O'Grady | Fabio Vistoli | Nancy Reinsmoen | Stefanie Thissen | Maria Koulmanda | Daniel Serón | Leo Roels | Fredy Rocuts | Ruta Jasaityte | |
| 1050 | Nt-Probnp Independently Predicts Graft Failure And Cvd In Renal Transplant Recipients | Health-Related Quality Of Life And Employment Status Of Liver Transplant Patients Compared To The General Population | Impact of Steroid Free Maintenance Immunosuppression on Graft and Patient Survival in Deceased Donor Kidney Transplantation | Hla Class Ii Mismatches In Renal Transplantation: Immunological Risk For Hummoral Alloreactivity | The Requirement Of The B7-H1 For Spontaneous Acceptance After Mouse Liver Allografting | T-Cell Help Is Essential In Memory B-Cell Alpha-Gal Xenoantibody Production:Implications For Abo Incompatible And Xenotransplantation | Donor-Recipient Age Matching Does Not Improve Years Of Graft Function In Deceased Donor Kidney Transplantation | Donation Patterns In 4 European Countries: Data From The Donor Action Database | A Significant Correlation Of Donor Pancreas Gene Expression Morphology With And Islet Function | Continuous-Flow Versus Pulsatile-Flow Lvads Used As A Bridge-To-Transplantation |
| Leendert Oterdoom | Fredrik Åberg | Silas Norman | ALIKI INIOTAKI | Miwa Morita | Jean Tchervenkov | Wai Lim | Leo Roels | Thomas Aloia | Alasdair Watson | |
| 1100 | Metabolic Syndrome Increases Risk Of Mortality In Renal Transplant Recipients | Health-Related Quality Of Life In Adult Transplant Recipients More Than 15 Years After Orthotopic Liver Transplantation. | Impact Of Center-Specific Pattern Of Use Of Steroid Free Maintenance Immunosuppression On Outcomes In Living Donor Kidney Transplantation | Cd20 Antigen Coated Beads For The Selective Removal Of Rituximab From Serum Prior To Crossmatch | Nk Cells Restrain Cd8 T Cells During Tolerance Induction To Islet Allografts | Accelerated Rejection Of Allografts Following Homeostatic Proliferation Of T Cells Despite Disproportionate Expansion Of Regulatory T Cells | Urine Magnetic Resonance Spectroscopy (Umrs): Preliminary Observations In The Deterioration Of Kidney Allograft Function (Dekaf) Study | Paired And Altruistic Living Kidney Donation In The Uk: Past, Present And Future | The Importance Of Tryptic-Like Activities For Human Islet Isolation | Being An Elderly Vad Recipient: Is It A Risk Factor For Death During The Bridge To Transplantation And Post-Heart Transplantation Period? |
| Aiko De Vries | Thomas Becker | Silas Norman | Benita Book | Ronald G. Gill | Wilson Wong | Robert Gaston | Rachel Johnson | Daniel Brandhorst | Alexis Shafii | |
| 1110 | Effect Of Candidate Health Status On Incremental Years Of Life From Kidney Transplantation | Liver Transplantation For Alcohol-Induced Liver Disease - A 10 Year Histological Follow-Up | Impdh Activity On Day 6 After Kidney Transplantation Is Significantly Related To The Risk Of Acute Rejection In Mmf Treated Patients | Clinical Importance Of Anti-Hla Specific Antibody Concentration In Performing Calculated Pra And Virtual Crossmatches | Donor-Derived Tolerogenic Dendritic Cells (Dc) Are Reprocessed By Recipient Dc To Down-Regulate The Anti-Donor Response And Promote Graft Survival | The Role Of Donor Cd4 T Cells Within Solid Organ Transplants In Graft Rejection | Four Stages And Lack Of Stable Accommodation In Chronic Alloantibody Mediated Renal Allograft Rejection In Cynomolgus Monkeys | Amount Of Antibody, As Expressed By Fluorescence Intensity, Does Not Correlate Nor Is Predictive Of Crossmatch Outcome | Effect Of Transportation On Human Islets | Heart Transplantation In Adult Patients With Extracorporeal Membrane Oxygenation Support |
| Alan Leightman | Maximilian Schmeding | Teunis Van Gelder | Smita Vaidya | Sherrie Divito | Thet Su Win | Rex Smith | Ronald Kerman | Elvira Jimenez-Vera | Ron-Bin Hsu | |
| 1120 | Prospective Evaluation Of The Risk Benefit Ratio Of A Vitamin D Treatment During The Early Period After Renal Transplantation | The Impact Of Poor Adherence To Medical Regimen In Liver Transplantation (Lt) | Early Steroid Withdrawal Following Renal Transplantation Increases The Risk Of Acute Rejection: A Meta-Analysis | A Virtual Cross-Match Protocol Significantly Increases Access Of Highly Sensitized Patients To Deceased Donor Kidney Transplantation | Location And Time Dependent Control Of Rejection By Regulatory T Cells Culminates In A Failure To Generate Memory T Cells | Cd8+ Memory T Cells Elicit Accelerated Rejection Through Rapid Recruitment Ofgr-1+ Neutrophils To The Allograft | Association Between De Novo Donor Specific Hla Antibody, C4D Staining In Renal Graft Biopsy, And Graft Outcome. | Volume-Outcome Relationship In The Procurement Of Transplantable Organs | Prevention Of Islet Allografts By Co-Transplanted Hepatic Stellate Cells Is Mediated By Treg Cell Local Expansion | Use Of Ecmo Salvage For Primary Allograft Failure Following Adult Cardiac Transplantation |
| Peter Stock | Patrizia Burra | Simon Knight | Francis Wright | Manuela Carvalho Gaspar | Nick Jones | Yong Cho | Joseph Scalea | Horng-Ren Yang | Alasdair Watson | |
| 1130 | Strategies For Diagnosis And Treatment Of Coronary Artery Disease In Renal Transplant Candidates: Impact On The Incidence Of Post-Transplant Cardiac Events. | De Novo Malignancy Following Liver Transplantation – Retrospective Analysis Of641 Liver Transplantations | Myfortic Vs. Cellcept: A Large, Single-Center Comparison | Final Clinical Trial Data Evaluating The Xm-One Endothelial Cell Crossmatch Testin Predicting Early Rejection Episodes In Renal Allograft Recipients. | Graft-Protective Regulatory T Cells Develop From Foxp3-Negative Precursors In Vivo | Allograft Rejection In Absence Of Secondary Lymphoid Organs | The Presence Of De Novo Donor Specific Antibody Predicts Poor Allograft Survival In Patient With Transplant Glomerulopathy | Increasing Organ Donation From The Emergency Department: A Precious Resource Wasted! | Real-Time Comprehensive Human Islet Assessment In Vitro Using Fluorescence Imaging And Microfluidic Perifusion System | Mechanical Circulatory Support After Cardiac Transplantation: The Modern Era |
| Jose JG Lima | Christian Graeb | Hans Sollinger | Andrea Zachary | Ross Francis | Caroline Leduc | Matthew Everly | Teressa Tymkewycz | Yong Wang | Alexis Shafii | |
| 1140 | Natural History Of Parathyroid Hormone (Pth) Levels In The First Year Post Kidney Transplantation (Tx) | Pre-Emptive Vs. Prophylactic Approach To Cytomegalovirus In Liver Transplantation | Pharmacokinetic And Pharmacodynamic Comparison Of An Initially Intensified Dosing Regimen Versus A Standard Dosing Regimen Of Enteric-Coated Mycophenolatesodium (Ec-Mps) In Renal Transplant Patients. | Antibodies To Hla Elicited By Peptides From Other Molecules | Rapid Recruitment Of Foxp3+ Regulatory T Cells Into Cardiac Allografts Following The Induction Of Specific Unresponsiveness To Alloantigen In Vivo | The Role Of Natural Killer Cells In Lymphocytic Choriomeningitis Virus (Lcmv) Induced Coronary Allograft Vasculopathy (Cav) | Clinical Value Of Routine Monitoring Of Hla Antibody And Urine Protein After Renal Transplantation | Health Status And Renal Function Evaluation Of Kidney Venders: A Report From Pakistan | Treatment With Exenatide Reduces Caspase-3 Activation And Apoptosis And Enhances Beta Cell Survival In Isolated Human Islets During Culture. | Use Of Extracorporeal Membrane Oxygenation In Adult Severe Respiratory Failure As A Bridge To Recovery Or Bridge To Lung Transplant |
| Rosemary Masterson | Gregory Smallwood | Klemens Budde | Paul Terasaki | Manuela Carvalho Gaspar | Jay Graham | Takaaki Kobayashi | Anwar Naqvi | Ziliang Ao | Emily Granger | |
| 1150 | Adverse Effects Of Hyperuricemia On Renal Transplant Outcome In Severity-Dependent Manner | Renal Function And Incidence Of Nodm With Enteric-Coated Mycophenolate Sodium In Combination With Reduced And Standard Tacrolimus Levels: Results Of A 6-Monthcomparative Study In De Novo Renal Transplant Recipients | A Non-Allogeneic Stimulus Triggers The Production Of De Novo Hla And Mica Antibodies. | Generating Allograft Tolerance By Baff-Dependant Expansion Of Regulatory T Cells | Nk Cells Regulate Graft-Versus-Host Disease And Cardiac Allograft Rejection By Limiting The Antigen-Driven Expansion Of Cd4 T Cells | Outcomes Of Patients Seeking Commercial Renal Allograft Transplantation Outside Of Australia | Factors That Influence Successful Clinical Islet Isolation When Using A Gmpcollagenase And Neutral Protease. | Bridging Patients From Veno-Venous Extracorporeal Membrane Oxygenation To Lung Transplant – Surgical Implications And Lessons Learned. | ||
| Sang Il Min | Laurence Chan | Luis E. Morales-Buenrostro | Stacey Walters | Magali Noval Rivas | Deborah Verran | Andrew Posselt | Emily Granger | |||
| 1230 - 1330 | Lunch | |||||||||
| 1200 - 1230 | Transplantation Society Business Meeting Parkside 110A |
|||||||||
| 1230 - 1300 | TSANZ Annual General Meeting Parkside 110B |
|||||||||
| 1200 - 1300 | Poster Session 4 | |||||||||
| 1200 - 1300 | Mini-Oral Session 25 THMO25 Hall 6 Presentation Booth 1 |
Mini-Oral Session 26 THMO26 Hall 6 Presentation Booth 2 |
Mini-Oral Session 27 THMO27 Hall 6 Presentation Booth 3 |
Mini-Oral Session 28 THMO28 Hall 6 Presentation Booth 4 |
Mini-Oral Session 29 THMO29 Hall 6 Presentation Booth 5 |
Mini-Oral Session 30 THMO30 Hall 6 Presentation Booth 6 |
Mini-Oral Session 31 THMO31 Hall 6 Presentation Booth 7 |
Mini-Oral Session 32 THMO32 Hall 6 Presentation Booth 8 |
||
| Renal 6: Long-term Outcomes and Comorbidities | Immunosuppression 4: Induction | Infectious Diseases 2: Emerging Issues | Immunobiology 4: Immunomodulation 2 | Liver 3: Outcomes | Late-Breaking | Malignancy | Immunobiology 5: Inflammation and Ischaemia | |||
| Chairs: Martin Gallagher, Jeffrey Wong | Chairs: Ian Hewitt, Kamal Sud | Chairs: Michael Ison, Adel Bakr | Chairs: David Goodman, Hilary Warren | Chairs: Simone Strasser, Luc Delriviere | Chairs: Ashely Irish, Kate Wyburn | Chairs: Ka Foon Chau, Germaine Wong | Chairs: Alex Bishop, Lee Anne Tibbles | |||
| 1200 | Outcome Of Hepatitis B, C Infection On Taiwanese Kidney Transplant Recipients With Tacrolimus And Mycophenolic Acid Based Immunosuppressants: A Single Center Study | Rituximab Induction In High Risk Kidney Transplant Recipients May Decrease The Incidence And Severity Of Recurrence Of Focal Segmental Glomerulosclerosis. | Post-Transplant Tuberculosis: Single Center Experience From The Developing World | Silencing Of Hla Class I Expression By Lentivirus Vector-Mediated Rna Interference Results In Resistance Of Primary Human Cells To Alloreactive Tcell-Mediated Cytotoxicity | Use Of Caspofungin Among Recipients Of Liver Transplants With High Index Of Suspicion For Fungal Infection. | YSPSL (rPSGL-Ig) for the Prevention of Delayed Graft Function (DGF): Results of Double-Blind, Placebo-Controlled, Multi-Center Phase I/II Safety and Efficacy Study | Risk Factors And Incidence Of Cancer In Renal Transplant Recipients Reported By Unos Between 1988 And 2006. | Adventital Vascular Progenitors Are Main Source Of Cells For Intimal Hyperplasia In Transplant Vasculopathy | ||
| Ming-Ju Wu | Junichiro Sageshima | Umapati Hegde | Nori Kasahara | Cataldo Doria | E. Steve Woodle | Mohammad Hossain | Piotr Religa | |||
| 1205 | Epidemiology Of Varicella Zoster Infection In Adult Renal Transplant Recipients | 200 Living Donor Kidney Transplantations Under Alemtuzumab Pre-Treatment And Weaning Of Tacrolimus Monotherapy: 3 Year Follow Up | Higher Risk Of Tuberculous Infections And Complications In Hepatitis B Or C Transplant Recipients Than Non-Carrier | Human Plasmacytoid Dendritic Cells Induce Profound Hyporesponsiveness And Suppressive Capacity In Allogeneic T-Cells | Sixty Living Donor Liver Transplantation For Wilson Disease. | NK Cell And T-cell Deletion Can Achieve Tolerance To The Innate And CognateImmune Response To HTF Transgenic Skin Grafts | Prevalence And Significance Of Lymph Proliferative Disorders After Solid Organ Transplants | Renal Ischemia Reperfusion Injury Is Abrogated By The Nos Cofactor Tetrahydrobiopterin Via Maintenance Of No Homeostasis And Stress Kinase Inhibition | ||
| Manish Kaushik | Henkie Tan | Bo Ying Choy | Herold Metselaar | Serguei Gautier | Hilton Gock | Tun Jie | Robert Sucher | |||
| 1210 | The Ten Years Follow Up Of Kidney Transplantation From Hbsag Positive Donors. | Antibody Induction Regimens In Renal Transplant Patients Display Differences In Total T Cell And B Cell But Not T-Regulatory Cell Recovery- Association With Rejection And Graft Survival | Respiratory Syncytial Virus Prophylaxis With Palivizumab In Pediatric Liver Transplant Recipients | Host Mhc Class I-Dependent Immunity Impairs Islet Xenograft Prolongation | Multidisciplinary Approach For Patients With Fulminant Hepatic Failure In The Era Of Living Donor Liver Transplantation | Cord blood Tregs can be pooled and effectively suppressive in mixed lymphocytecultures. | Risk For Non-Hodgkin Lymphoma Following Renal Transplantation Is Associated With Currency Of Receipt Of Immunosuppression And Reverts To Normal On Cessation | Dampening Of Alloimmunity By Toll-Like Receptor 4 Desensitization | ||
| Atiporn Ingsathit | Manuel R. Carreño | Andrew Campbell | Ronald G. Gill | Tsuyoshi Shimamura | Daniel Figueroa-Tentori | Marina van Leeuwen | Nicolas Vanrompaey | |||
| 1215 | Impact Of Pretransplant Anti Hcv Antibody Status And Type Of Immunosuppression On Outcomes In Renal Transplant Recipients Infected With Hepatitis C Virus | Calcineurin Inhibitors-Free Immunosuppression In Expanded Criteria Donor Kidneys: Comparison Between Two Induction Eras. | Benefits Of Isoniazid Chemoprophylaxis In Renal Transplant Recipients | Cd300A And Cd300C On Plasmacytoid Dendritic Cells Are Down-Regulated By Tlr7 Andtlr9 Ligand Induced Type I Interferon | Hepatic Angiosarcoma (Has) : The (Last) Absolute Contra-Indication To Liver Transplantation (Lt) Report Of The European Liver Transplant Registry (Eltr). | MRI Assessment Of Liver Ischemia After Intraportal Islet Transplantation | The Incidence And Management Of Kaposi's Sarcoma After Kidney Transplantation Reported By Unos Between 1994 And 2005 | Protection Against Renal Ischemia Injury In Dna-Repair Deficient Cockayne Syndrome Mice | ||
| Mukut Minz | Luis Santiago Re | Anwar Naqvi | Derek Hart | Jan Lerut | Eba Hathout | Mohamed Morsy | Ron De Bruin | |||
| 1220 | Significant Impact Of Serum Adiponectin Levels On Insulin Resistance In New Onset Diabetes After Renal Transplantation | A Prospective Randomized Trial Of Alemtuzumab Versus Rabbit Anti-Thymocyte Globulin Induction In Kidney And Pancreas Transplantation: Minimum 6 Months Follow-Up | Syk, A Novel Therapeutic Target For Ptld, Drives Epstein Barr Virus (Ebv)+ Bcell Lymphoma Growth And Survival Through Activation Of The Pi3K/Akt Pathway |
T Cells Acquire Hla-G Via Trogocytosis From Genetically Modified Human Dendritic Cells During Alloimmune Activation | Novel Clinical Monitoring Of Cell Mediated Immunity (Cmi) Using Immunknow® In Liver Transplant Recipients Provides Optimal Immune Suppression And Improved Outcomes | Gene expression profiling of human islets to determine predictors of clinical islet transplant outcomes | Chronologically Different Incidence Of Post-Transplant Malignancy In Renal Transplant Recipients; 25 Years Experience In Korean Single Center | Intracellular Signaling Pathways As Targets For The Prevention Of Ischemia/Reperfusion-Induced Damage During Solid Organ Transplantation | ||
| Kenji Nishimura | Alan Farney | Olivia Hatton | Boris Fedoric | Anthony Sebastian | Shane Grey | Kya Ha Huh | Jakob Troppmair | |||
| 1225 | Stress Echocardiography For Assessment Of Renal Transplant Recipients: Analysis Of Cardiac Outcomes. | Immune Reconstitution In Human Renal Allograft Recipients Treated By Sirolimus Or Cyclosporin After Thymoglobulin Induction Therapy | Role Of Heterologous Immunity In Rejection Of Skin And Islet Grafts | Long-Term Complications In Liver Transplantation From Uncontrolled Non-Heart-Beating Donors | The Outcome Of Commercial Kidney Transplantation: A Qatari Study On Preoperative And Post-Transplant Follow-Up Records Of Patients Having Commercial Renal Transplantation Abroad | Treatment Of Central Nervous System Post Transplant Lympho Proliferative Disorder With High Dose Iv Methotrexate | A Novel Sirna-Delivery Method Through Coronal Artery Infusion Of Donor Hearts For Preventing Ischemia-Reperfusion Injury | |||
| Christopher Hood | Emmanuel Morelon | Barbara Fazekas De St. Groth | Joohyun Kim | Riadh Fadhil | Clifton Kew II | Xiufen Zheng | ||||
| 1230 | Post Transplantation Diabetes Mellitus: Role Of Insulin-Resistance And Pro-Inflammatory Cytokines In First Year Post-Transplant | 5 Year Outcomes In A Randomized Trial Comparing Rabbit Antithymocyte Globulin And Basiliximab In Kidney Transplant Recipients: Linking Clinical Trial Data With Registry Data | Induction Of Immunosuppressive Dendritic Cells By A Novel Nuclear Factor-Kappa B Inhibitor, Dhmeq | Renal Function In Liver Transplant Recipients: The Try Study. | Voclosporin (ISA 247): The Phase 2 'PROMISE' de novo Renal Transplant Trial Demonstrates Efficacy And An Improved Safety Profile Across A Wide Therapeutic Range | Rates Of Human Papillomavirus (Hpv)-Related Cancers Are Increased In Renal Transplant Recipients And Return To Low Levels On Cessation Of Immunesuppression. | Inhibition Of Th17 Cells Regulates Autoimmune Diabetes. | |||
| Mario Carmellini | Daniel C. Brennan | Takeshi Aoyagi | Faouzi Saliba | Stephan Busque | Andrew Grulich | Juliet Emamaullee | ||||
| 1235 | Reversal Of Metabolic Syndrome Post-Kidney Transplantation In Chronic Corticosteroid Versus Early Corticosteroid Withdrawal Regimens | Long-Term Immunological Effects Of Atg Induction Therapy | A Novel Immunotoxin Has Cytotoxicity To Ctla-4 Positive Cells With Specificity | Role Of Dcd Organs In Simultaneous Liver-Kidney Transplantation | Risk Of Cutaneous Melanoma Does Not Increase Over Time After Renal Transplantation | A Multicenter Rct Of Deceased Organ Donor Pre-Treatment With Corticosteroids For The Prevention Of Post Ischemic Acute Renal Failure | ||||
| E. Steve Woodle | Rolf Weimer | Huawei Cai | Winston Hewitt | Claire Vajdic | Julia Wilflingseder | |||||
| 1240 | Determinants Of Bone Density In Renal Tx Recipients And Its Correlation With Vitd, Calcium And Bisphosphonates- A South Indian Experience | Atg Versus Basiliximab Induction Therapy In Kidney Allograft Recipients Receiving A Dual Immunosuppressive Regimen: Six-Year Results | The Allogeneic Reaction Can Induce Generation Of Semi-Mature Regulatory Dendritic Cells Through Cytokine Secretion: Major Role For Ifn Gamma | Outcome Of Saudi And Egyptian Patients Receiving Cadaveric Liver Transplantation In China | Cancer Mortality In Kidney Transplant Recipients | Donor Angiotensin Ii Receptor Type 1 Expression Critically Involves The Development Of Acute Rejection | ||||
| Priyanka Govindan | Andreas Pascher | Assia Eljaafari | Naglaa Allam Ahmed Allam | Bryce Kiberd | Jun-Ichi Suzuki | |||||
| 1245 | Transplant Erythrocytosis: A Disappearing Phenomena? | Low Dose Thymoglobulin Versus Simulect Induction In Adult Kidney Transplant With Cni Triple Immunosuppression: Efficacy And Safety | Prolonged Survival Of Composite Tissue Allografts Associated With Post-Transplant Lymphoproliferative Disorder In A Non-Human Primate Model | Is Screening For Cervical Cancer In Kidney Transplant Recipients Cost-Effective? The Costs And Health Benefits Of Screening For Cervical Cancer In Women With Kidney Transplants | ||||||
| Bryce Kiberd | Mark Reza Laftavi | Rolf Barth | Germaine Wong | |||||||
| 1250 | Thymoglobulin Dosing Intensity And Density: Effects On Induction Efficacy In Early Corticosteroid Withdrawal Regimens | The Health And Economic Impact Of Human Papillomavirus Vaccination In Kidney Transplant Recipients | ||||||||
| E. Steve Woodle | Germaine Wong | |||||||||
| 1255 | Efficacy Of A Novel Rabbit Anti-Human Leukocyte Polyclonal Antibody In Preventing Acute Renal Allograft Rejection In Nonhuman Primates | Cancer Screening Practices By Transplant Physicians: What Do Physicians Screen For And Why? | ||||||||
| Zidong Liu | Germaine Wong | |||||||||
 Roche Sponsored Symposium |
||||||||||
| 1200 - 1330 | World Heritage of The Kidney Bayside Grand Hall |
|||||||||
| Chair: David Goldsmith | ||||||||||
| 1200 | Opening | |||||||||
| David Goldsmith (UK) | ||||||||||
| 1210 | In/Direct effects of CMV | |||||||||
| Cecilia Naucler (Sweden) | ||||||||||
| 1230 | CNI nephrotoxicity | |||||||||
| Robert Gaston (USA) | ||||||||||
| 1250 | Anaemia in transplant patients | |||||||||
| David Goldsmith (UK) | ||||||||||
| 1320 | Audience Questions | |||||||||
| 1320 | Closing | |||||||||
| David Goldsmith (UK) | ||||||||||
| 1330 - 1500 | State-of-the-Art Symposium Concurrent Session 31 STA31 Bayside Auditorium B |
State-of-the-Art Symposium Concurrent Session 32 STA32 Parkside Auditorium |
State-of-the-Art Symposium Concurrent Session 33 STA33 Bayside Auditorium A |
State-of-the-Art Symposium Concurrent Session 34 STA34 Bayside Room 102 |
State-of-the-Art Symposium Concurrent Session 35 STA35 Parkside Ballroom B |
State-of-the-Art Symposium Concurrent Session 36 STA36 Parkside 110A |
State-of-the-Art Symposium Concurrent Session 37 STA37 Bayside Room 204 A & B |
State-of-the-Art Symposium Concurrent Session 38 STA38 Bayside Gallery |
State-of-the-Art Symposium Concurrent Session 39 STA39 Bayside 103 |
State-of-the-Art Symposium Concurrent Session 40 STA40 Parkside 110 B |
| Living Donor Transplantation: Are the Outcomes Good Enough? | Long Term Outcomes in Liver Transplantation | Update on New Immunosuppressive Trials in Transplantation | mTOR Inhibitors in Thoracic Transplantation | Local Control of Immune Activation | Novel Treatment Paradigms for Islet Transplantation | Ethical Issues in donation and Transplantation | Strategies for diagnosis of infection in the transplant patient | Multipotent Stem Cells and Potential for Tissue Repair | Immune Mechanisms and Treatment Strategies in the Highly Sensitised Patient | |
| Chairs: Rutger Ploeg, James Mackie | Chairs: Geoffrey McCaughan | Chairs: Allan Kirk, Woflgang Arns | Chairs: Bruno Meiser, Andreas Zuckermann | Chairs: Wayne Hancock, Hans Schlitt | Chairs: AN Balamurugan, Jenny Gunton | Chairs: Annika Tibell, Miles Little | Chairs: Jay Fishman, Atul Humar | Chairs: Kerry Atkinson, Bernard Tuch | Chairs: Marlene Rose, Andrew Bushell | |
| 1330 | Kidney Outcomes for Recipients of Living Donor Kidneys | Is There Chronic Liver Allograft Hepatopathy? | A prospective,randomised,placebo controlled,multicenter study of the efficacy and safety of rituximab as induction therapy together with tacrolimus,mycophenolate mofetil and steroids in renal transplantation | Overview of Mechanism of Action of mTOR Inhibitors | The Role of Ischaemia Reperfusion Injury on Graft Outcome | Current Challenges in Islet Transplantation | The Global Role of the TTS Ethics Committee | New Ways to Diagnose Fungal Infections and Assess Their Clinical Impact | Directed Differentiation of Embryonic Stem Cells | Molecular Aspects of Alloimmunisation |
| Robert Gaston (Birmingham, USA) | Stefan Hubscher (Birmingham, UK) | Gunnar Tyden (Stockholm, Sweden) | Paul Corris (Newcastle Upon Tyne, UK) | Jerzy Kupiec-Weglinski (Los Angeles, USA) | Rodolfo Alejandro (Miami, USA) | Annika Tibell (Stockholm, Sweden) | Kieren Marr (Portland, USA) | Andrew Elefanty (Melbourne, Australia) | James McCluskey (Melbourne, Australia) | |
| 1400 | Living Donation in At Risk Populations | Strategies to Reduce Cardiovascular and Chronic Renal Failure Risk Factors | Opticept Trial: Efficacy and Safety of Monitored MMF In Combination with CNI In Renal Transplantation At 1 and 2 Years | The Role of mTOR Inhibitors in Cardiac Transplantation | Role of Complement in Alloimmune Activation-Diagnostic and Therapeutic Implications | How Close Are We to a Successful Clinical Tolerance Protocol? | Allocation of Donor Organs: Utility versus Equity | Donor Derived Infections, and Screening and Strategies for Avoiding Them in Transplant Recipients | Generation of pluipotent stem cells from somatic cells and their potential clinical application | Solid Phase Assay of Antibody Identification and Their Clinical Relevance |
| Connie Davis (Seattle, USA) | Simone Strasser (Sydney, Australia) | Roy Bloom (Philadelphia, USA) | Anne Keogh (Sydney, Australia) | Steven Sacks (London, UK) | Camillo Ricordi (Miami, USA) | Kevin O'Connor (Newton, USA) | Camille Kotton (Boston, USA) | Andrew Laslett (Melbourne, Australia) | Andrea Zachary (Baltimore, USA) | |
| 1430 | Settling Psychosocial Barriers | What About Total Withdrawal of Immunosuppression? | A Multicenter, Randomized, Double Blind, Placebo-Controlled Trial of Early Corticosteroid Cessation: Final Five Year Report | The Role of mTOR Inhibitors in Lung Transplantation | Heparanase as a Mechanism and as a Target | Does Islet Transplantation Offer a Realistic Alternative to Pancreas Transplantation? | Directed and Conditional Donation from Deceased Donors - What is Acceptable? | Novel Diagnostics for Viral Infections and Their Use in Driving Therapy | Pluripotent Adult Stem Cells for Treatment of Acute Cardiovascular Ischemic Injury | Impact of Donor Specific Antibody on Graft Outcome |
| Jan J. van Busschbach (Rotterdam, The Netherlands) | Jan Lerut (Brussels, Belgium) | E. Steve Woodle (Cincinnati, USA) | Allan Glanville (Sydney, Australia) | Chris Parish (Canberra, Australia) | Peter Stock (San Francisco, USA) | Douglas Hanto (Boston, USA) | Jay Fishman (Boston, USA) | Robert Deans (Riverside, USA) | Elaine Reed (Los Angeles, USA) | |
| Tacrolimus Once-Daily Prolonged Release Versus Tacrolimus Twice-Daily In Combination With Steroids - A Phase Iii Multicentre Liver Study | ||||||||||
| Pavel Trunecka (Prague, Czech Republic) | ||||||||||
| 1500 - 1600 | Concurrent Oral Session 61 THO61 Bayside Auditorium B |
Concurrent Oral Session 62 THO62 Parkside Auditorium |
Concurrent Oral Session 63 THO63 Bayside Auditorium A |
Concurrent Oral Session 64 THO64 Bayside Room 102 |
Concurrent Oral Session 65 THO65 Parkside Ballroom B |
Concurrent Oral Session 66 THO66 Parkside 110A |
Concurrent Oral Session 67 THO67 Bayside Room 204 A & B |
Concurrent Oral Session 68 THO68 Bayside Gallery |
Concurrent Oral Session 69 THO69 Bayside Room 103 |
Concurrent Oral Session 70 THO70 Parkside 110 B |
| Living Donor Renal Transplants | Experimental Liver Transplantation | Induction Immunusuppression | Biomarkers of Acute Rejection | Immunobiology/HLA | Composite Grafts | Surgical Dilemmas in Renal Transplantation | Quality of Life | Xenotransplantation - Immunosuppression and PERV | mTOR Inhibition in Cardiothoracic Transplantation | |
| Chairs: Dae Joong Kim, Arthur Vasilaras | Chairs: Ferdinand Mühlbacher, Norman Kneteman | Chairs: Lionel Rostaing | Chairs: Peter Nickerson, Sophie Brouard | Chairs: Frank Christiansen, James McCluskey | Chairs: Jean-Michel Dubernard, Marco Lanzetta | Chairs: Richard Allen, Piyanut Pootracool | Chairs: Francis Delmonico, Sean Kennedy | Chairs: Kieran Marr, Wei Wang | Chairs: John Dark, Anne Keogh | |
| 1500 | Testing Willingness For Living Kidney Donation: An Option For All Patients? | Insights Into The Interaction Of Tissue Cells With Infiltrating Cd8+ T Cells In Liver Transplant Tolerance Using A Tcr Transgene Approach | Alemtuzumab Induction In Living Donor Kidney Transplantation: An Analysis Using The Optn/Unos Database | Differential Expression Of Bmp-7, Tgfâ1 And Granzyme B During Acute Rejection Of Human Renal Allografts: A Plausible Molecular Link Between Acute Rejection And Chronic Allograft Injury | Double-Negative Regulatory T Cells Based Therapeutic Approach To Prevent And Cure Type I Diabetes In Nod Mice. | First Face Allograft In Human: A Two Years Follow Up | Assessment For Renal Transplantation In The United Kingdom And Impact Of Patient Comorbidity On Access To The Waiting List | Transplantation Of Older Patients Does Not Improve Survival Compared With Those Wait Listed. Analysis Of 9,700 Wait Listed Patients In The Uk | Local Expression Of Immunomodulatory Molecules Inhibits Xenogeneic Responses In Vitro And In Vivo | Biopsy-Proven Acute Rejection And Recurrent Rejection In De Novo Cardiac Transplant Recipients: Superior Efficacy With Everolimus |
| Leonieke Kranenburg | Zhong Chen | Suphamai Bunnapradist | Manikkam Suthanthiran | Dong Zhang | Emmanuel Morelon | Deepika Akolekar | David Ansell | Mauro Sandrin | Elke Lehmkuhl | |
| 1512 | Time 0 Living Kidney Donor Biopsy: A Valuable Opportunity To Correlate Predonation Clinical Data With Histological Abnormalities. | Cytoprotective Action Of A Co-Releasing Molecule (Corm-3) In A Novel Model Of Pig Liver Ischemia/Reperfusion Injury | 12 Month Results Of A Multicenter, Randomized Trial Comparing Three Induction Agents (Alemtuzumab, Thymoglobulin And Basiliximab) With Tacrolimus, Mycophenolate Mofetil And A Rapid Steroid Withdrawal In Renal Transplantation | Tim3 Mrna Quantification In The Peripheral Blood And Urinary Sediment Cells Allows An Accurate Diagnosis Of Acute Rejection Of Kidney Allografts. | The Critical Role Of Cd4 T Cells In Cd154 Blockade-Resistant Memory Cd8 T Cell Activation And Allograft Rejection In Sensitized Recipients | International Registry On Hand And Composite Tissue Transplantation | The Organ Shortage On The Balkans- Pakistan, The Promising Land! | Removing Financial Barriers To Living Organ Donation: British Columbia Pilots Expense Reimbursement | Transduction Of Neonatal Porcine Islets By Aav-Ctla-4-Ig Provided Local Protection Of Porcine Islet Xenografts From Human T-Cell Mediated Rejection In Vivo | Efficacy And Safety Of Everolimus Switching In Heart Transplant Recipients. A Multicenter Retrospective Study |
| Eduardo Mancilla Urrea | Emanuele Cozzi | E. Steve Woodle | Roberto Manfro | Jerzy Kupiec-Weglinski | Palmina Petruzzo | Zivko Popov | M.Y. Lorraine Gerard | Wei Wang | Nicolas Manito | |
| 1524 | The Assessment Of Elderly Donors Aged Over 65 Years For Living Related Kidney Transplantation By 99Mtc Mercapto-Acetyl-Triglycine (Mag3) | Effect Of Hypoxia/Reoxygenation On Trail-Trail Receptor Dr4 And Dr5 Pathway In Human Intrahepatic Cholangiocytes | 411 Living Donor Kidney Transplants Using Alemtuzumab Pre-Conditioning And Tacrolimus Monotherapy: 5 Year Experience | Identification Of Potential Biomarker For Acute Rejection Of Renal Transplant In Urinary Cell Pellets | Donor-Specific Antibodies Are Produced By B220+/Cd20+/ Cd5-/Igm+/Igd+ B Cells Regulated By Th1 Cytokines: A Study Using A Novel Murine Model Of Hla Sensitization | Monitoring Rejection In Hand Transplantation By A 'Distant Sentinel Skin Graft' | Factors Influencing The Number Of Hospitalization Days In The First Three Months After Kidney Transplantation | Older Living Kidney Donors: Surgical Outcome And Quality Of Life | Adenovirus-Mediated Gene Expression Of Human C-Flipl Protects Pig Islets Against Human Cd8+ Ctl-Mediated Cytotoxicity | Immunosuppression With Everolimus In Pediatric Heart Transplantation |
| Hidetaka Ushigome | Liang Wei | Henkie Tan | Lihua Ying | Andrew Klein | Marco Lanzetta | Martin Heemskerk | Robert Minnee | Masahiro Tanemura | Elke Lehmkuhl | |
| 1536 | Renal Outcomes In African-American Living Kidney Donors | Inhibition Of Inducible Nitric Oxide Synthase (Inos) By 1400W Improves The Outcome After Transplantation Of Fatty Partial Liver Grafts | Thymoglobulin Induction In Living Donor Renal Transplant Recipients: Update Of The Tailor Registry | Leucocyte Elastase-α1Protease Inhibitor Complex - Neutrophil Degranulation Marker In Plasma And Urine Of Patients After Deceased Renal Allograft Transplantation. Assessment Of Inducing Factors And Impact On Allograft Function. | Human Regulatory T Cell Therapy In The Prevention Of Transplant Arteriosclerosis | Vascularized Bone Marrow Transplant As An Alternative To Conventional Cellular Bone Marrow Transplantation | Health-Related Quality Of Life Outcomes For Kidney Donors Differ Depending On Type Of Laparoscopic Donor Nephrectomy (Pure (P-Ldn) Vs. Hand-Assist (Ha-Ldn)) | Establishing An Indigenous Live Donor Kidney Transplant Programme In Nigeria | Rapamycin Promotes The Enrichment Of Cd4+Cd25Hifoxp3+ T Regulatory Cells From Naive Cd4+ T Cells Of Baboon That Suppress Anti Porcine Xenogenic Response In Vitro | Safety And Efficacy Of Statin Therapy In Patients Switched From Cyclosporine Ato Sirolimus After Cardiac Transplantation |
| Matthew Cooper | Zhi Zhong | Stefan Hemmerich | Malgorzata Zynek-Litwin | Kathryn Wood | Ion Zegrea | Michael Hughes | Paul Lear | Muhammad Mohiuddin | Andreas Zuckermann | |
| 1548 | African American Women And Older Patients Have A Greater Decline In Renal Function Following Living Kidney Donation | Distinct Gene Signatures Linked To Acute Phase Injury And Tumor Invasiveness After Liver Transplantation Using Small-For-Size Grafts – The Significance Ofip10 On Tumor Invasion-Related Properties And Tumor-Associated Macrophage Infiltration | 20 Year Follow-Up Results Of A Randomized Controlled Trial Comparing Anti-Lymphocyte Globulin-Induction To No Induction In Renal Transplant Patients | Reliable And Simple Diagnosis Of Renal Allograft Rejection Based On Urinary Granzyme A | A Novel Dna Vaccination Strategy For Transplantation | Investigation Of Lymphocyte Adhesion And Trafficking Markers In Rejection Of The Skin Component In Human Hand Allografts | Should Kidney Transplantation Be Considered The Treatment Of Choice For Systolic Heart Failure In Patients With End Stage Renal Disease? | Dual Kidney Transplants From Very Old Or Very Young Donors; Long Term Outcomes And Complications | Perv Free Swine In A Defined Pathogen Free Herd | Impact Of Ace-Inhibitor And Angiotensin Receptor Blocker Therapy On Development Of Proteinuria After Switch To Sirolimus In Cardiac Transplant Recipients |
| Mark Reza Laftavi | Kwan Man | Marcelo Cantarovich | Ajda Rowshani | Alice Li | Stefan Schneeberger | Ravinder Wali | Mark Reza Laftavi | William Beschorner | Arezu Aliabadi | |
| 1600 - 1700 | Plenary Session 5 PL05 Bayside Auditorium B |
|||||||||
| What's Hot and What's Not? | ||||||||||
| Chairs: Jeremy Chapman, Paul Keown | ||||||||||
| 1600 | What is Hot in T Cell Immunity | |||||||||
| Peter Doherty (Melbourne, Australia) | ||||||||||
| 1630 | Summary of Clinical Advances | |||||||||
| Peter Morris (London, UK) | ||||||||||
| 1700 | Close | |||||||||